Unknown

Dataset Information

0

GPR84 and TREM-1 Signaling Contribute to the Pathogenesis of Reflux Esophagitis.


ABSTRACT: Gastro-esophageal reflux disease (GERD) is one of the most common disorders in gastroenterology. Patients present with or without increased acid exposure indicating a nonuniform etiology. Thus, the common treatment with proton pump inhibitors (PPIs) fails to control symptoms in up to 40% of patients. To further elucidate the pathophysiology of the condition and explore new treatment targets, transcriptomics, proteomics and histological methods were applied to a surgically induced subchronic reflux esophagitis model in Wistar rats after treatment with either omeprazole (PPI) or STW5, a herbal preparation shown to ameliorate esophagitis without affecting refluxate pH. The normal human esophageal squamous cell line HET-1A and human endoscopic biopsies were used to confirm our findings to the G-protein-coupled receptor (GPR) 84 in human tissue. Both treatments reduced reflux-induced macroscopic and microscopic lesions of the esophagi as well as known proinflammatory cytokines. Proteomic and transcriptomic analyses identified CINC1-3, MIP-1/3?, MIG, RANTES and interleukin (IL)-1? as prominent mediators in GERD. Most regulated cyto-/chemokines are linked to the TREM-1 signaling pathway. The fatty acid receptor GPR84 was upregulated in esophagitis but significantly decreased in treated groups, a finding supported by Western blot and immunohistochemistry in both rat tissue and HET-1A cells. GPR84 was also found to be significantly upregulated in patients with grade B reflux esophagitis. The expression of GPR84 in esophageal tissue and its potential involvement in GERD are reported for the first time. IL-8 (CINC1-3) and the TREM-1 signaling pathway are proposed, besides GPR84, to play an important role in the pathogenesis of GERD.org.

SUBMITTER: Abdel-Aziz H 

PROVIDER: S-EPMC4982478 | biostudies-literature | 2016 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications


Gastro-esophageal reflux disease (GERD) is one of the most common disorders in gastroenterology. Patients present with or without increased acid exposure indicating a nonuniform etiology. Thus, the common treatment with proton pump inhibitors (PPIs) fails to control symptoms in up to 40% of patients. To further elucidate the pathophysiology of the condition and explore new treatment targets, transcriptomics, proteomics and histological methods were applied to a surgically induced subchronic refl  ...[more]

Similar Datasets

| S-EPMC6542463 | biostudies-literature
| S-EPMC3025696 | biostudies-literature
| S-EPMC6196785 | biostudies-other
| S-EPMC2699601 | biostudies-literature
| S-EPMC6175686 | biostudies-literature
| S-EPMC2194642 | biostudies-literature
| S-EPMC8752236 | biostudies-literature
| S-EPMC7458243 | biostudies-literature
2017-03-15 | GSE94719 | GEO
| S-EPMC5578003 | biostudies-literature